697 related articles for article (PubMed ID: 31931403)
1. Arterial spin labeling versus
Dolui S; Li Z; Nasrallah IM; Detre JA; Wolk DA
Neuroimage Clin; 2020; 25():102146. PubMed ID: 31931403
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer Disease and Mild Cognitive Impairment: Integrated Pulsed Arterial Spin-Labeling MRI and
Riederer I; Bohn KP; Preibisch C; Wiedemann E; Zimmer C; Alexopoulos P; Förster S
Radiology; 2018 Jul; 288(1):198-206. PubMed ID: 29762090
[TBL] [Abstract][Full Text] [Related]
3. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
Tosun D; Schuff N; Jagust W; Weiner MW;
Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
[TBL] [Abstract][Full Text] [Related]
4. Comparison of PASL, PCASL, and background-suppressed 3D PCASL in mild cognitive impairment.
Dolui S; Vidorreta M; Wang Z; Nasrallah IM; Alavi A; Wolk DA; Detre JA
Hum Brain Mapp; 2017 Oct; 38(10):5260-5273. PubMed ID: 28737289
[TBL] [Abstract][Full Text] [Related]
5. Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET.
Nedelska Z; Senjem ML; Przybelski SA; Lesnick TG; Lowe VJ; Boeve BF; Arani A; Vemuri P; Graff-Radford J; Ferman TJ; Jones DT; Savica R; Knopman DS; Petersen RC; Jack CR; Kantarci K
Neuroimage Clin; 2018; 19():939-947. PubMed ID: 30003031
[TBL] [Abstract][Full Text] [Related]
6. Cerebral Hypoperfusion and Hypometabolism Detected by Arterial Spin Labeling MRI and FDG-PET in Early-Onset Alzheimer's Disease.
Verclytte S; Lopes R; Lenfant P; Rollin A; Semah F; Leclerc X; Pasquier F; Delmaire C
J Neuroimaging; 2016; 26(2):207-12. PubMed ID: 26031943
[TBL] [Abstract][Full Text] [Related]
7. A brain stress test: Cerebral perfusion during memory encoding in mild cognitive impairment.
Xie L; Dolui S; Das SR; Stockbower GE; Daffner M; Rao H; Yushkevich PA; Detre JA; Wolk DA
Neuroimage Clin; 2016; 11():388-397. PubMed ID: 27222794
[TBL] [Abstract][Full Text] [Related]
8. Cerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: two sides of the same coin?
Verfaillie SC; Adriaanse SM; Binnewijzend MA; Benedictus MR; Ossenkoppele R; Wattjes MP; Pijnenburg YA; van der Flier WM; Lammertsma AA; Kuijer JP; Boellaard R; Scheltens P; van Berckel BN; Barkhof F
Eur Radiol; 2015 Oct; 25(10):3050-9. PubMed ID: 25899416
[TBL] [Abstract][Full Text] [Related]
9. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
[TBL] [Abstract][Full Text] [Related]
10. Cerebral metabolism and perfusion in MR-negative individuals with refractory focal epilepsy assessed by simultaneous acquisition of (18)F-FDG PET and arterial spin labeling.
Boscolo Galazzo I; Mattoli MV; Pizzini FB; De Vita E; Barnes A; Duncan JS; Jäger HR; Golay X; Bomanji JB; Koepp M; Groves AM; Fraioli F
Neuroimage Clin; 2016; 11():648-657. PubMed ID: 27222796
[TBL] [Abstract][Full Text] [Related]
11. Precuneus and Cingulate Cortex Atrophy and Hypometabolism in Patients with Alzheimer's Disease and Mild Cognitive Impairment: MRI and (18)F-FDG PET Quantitative Analysis Using FreeSurfer.
Bailly M; Destrieux C; Hommet C; Mondon K; Cottier JP; Beaufils E; Vierron E; Vercouillie J; Ibazizene M; Voisin T; Payoux P; Barré L; Camus V; Guilloteau D; Ribeiro MJ
Biomed Res Int; 2015; 2015():583931. PubMed ID: 26346648
[TBL] [Abstract][Full Text] [Related]
12. Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease.
Musiek ES; Chen Y; Korczykowski M; Saboury B; Martinez PM; Reddin JS; Alavi A; Kimberg DY; Wolk DA; Julin P; Newberg AB; Arnold SE; Detre JA
Alzheimers Dement; 2012 Jan; 8(1):51-9. PubMed ID: 22018493
[TBL] [Abstract][Full Text] [Related]
13. Principal-Component Analysis-Based Measures of PET Data Closely Reflect Neuropathologic Staging Schemes.
Blazhenets G; Frings L; Sörensen A; Meyer PT;
J Nucl Med; 2021 Jun; 62(6):855-860. PubMed ID: 33097630
[TBL] [Abstract][Full Text] [Related]
14. Pattern of cerebral hyperperfusion in Alzheimer's disease and amnestic mild cognitive impairment using voxel-based analysis of 3D arterial spin-labeling imaging: initial experience.
Ding B; Ling HW; Zhang Y; Huang J; Zhang H; Wang T; Yan FH
Clin Interv Aging; 2014; 9():493-500. PubMed ID: 24707173
[TBL] [Abstract][Full Text] [Related]
15. The Cingulate Island Sign on FDG-PET vs. IMP-SPECT to Assess Mild Cognitive Impairment in Alzheimer's Disease vs. Dementia with Lewy Bodies.
Chiba Y; Fujishiro H; Iseki E; Kasanuki K; Sato K
J Neuroimaging; 2019 Nov; 29(6):712-720. PubMed ID: 31199036
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of 18F-FDG-PET/MRI brain in dementia: Preliminary experience from a geriatric clinic in South India.
Mukku SSR; Sivakumar PT; Nagaraj C; Mangalore S; Harbishettar V; Varghese M
Asian J Psychiatr; 2019 Aug; 44():99-105. PubMed ID: 31336358
[TBL] [Abstract][Full Text] [Related]
17. Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease.
Chen Y; Wolk DA; Reddin JS; Korczykowski M; Martinez PM; Musiek ES; Newberg AB; Julin P; Arnold SE; Greenberg JH; Detre JA
Neurology; 2011 Nov; 77(22):1977-85. PubMed ID: 22094481
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of conversion of mild cognitive impairment to Alzheimer's dementia by voxel-wise Cox regression based on FDG PET data.
Sörensen A; Blazhenets G; Rücker G; Schiller F; Meyer PT; Frings L;
Neuroimage Clin; 2019; 21():101637. PubMed ID: 30553760
[TBL] [Abstract][Full Text] [Related]
19. The effect of ApoE ε4 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study.
Paranjpe MD; Chen X; Liu M; Paranjpe I; Leal JP; Wang R; Pomper MG; Wong DF; Benzinger TLS; Zhou Y;
Neuroimage Clin; 2019; 22():101795. PubMed ID: 30991617
[TBL] [Abstract][Full Text] [Related]
20. Cerebral Blood Flow Predicts Conversion of Mild Cognitive Impairment into Alzheimer's Disease and Cognitive Decline: An Arterial Spin Labeling Follow-up Study.
Duan W; Zhou GD; Balachandrasekaran A; Bhumkar AB; Boraste PB; Becker JT; Kuller LH; Lopez OL; Gach HM; Dai W
J Alzheimers Dis; 2021; 82(1):293-305. PubMed ID: 34024834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
